193 related articles for article (PubMed ID: 33843258)
1. Consensus Decision-Making for the Management of Antiplatelet Therapy before Non-Cardiac Surgery in Patients Who Underwent Percutaneous Coronary Intervention With Second-Generation Drug-Eluting Stents: A Cohort Study.
Kim C; Kim JS; Kim H; Ahn SG; Cho S; Lee OH; Park JK; Shin S; Moon JY; Won H; Suh Y; Cho JR; Cho YH; Oh SJ; Lee BK; Hong SJ; Shin DH; Ahn CM; Kim BK; Ko YG; Choi D; Hong MK; Jang Y
J Am Heart Assoc; 2021 Apr; 10(8):e020079. PubMed ID: 33843258
[TBL] [Abstract][Full Text] [Related]
2. Patterns of Antiplatelet Therapy During Noncardiac Surgery in Patients With Second-Generation Drug-Eluting Stents.
Kim C; Kim JS; Kim H; Ahn SG; Cho S; Lee OH; Park JK; Shin S; Moon JY; Won H; Suh Y; Cho JR; Cho YH; Oh SJ; Lee BK; Hong SJ; Shin DH; Ahn CM; Kim BK; Ko YG; Choi D; Hong MK; Jang Y
J Am Heart Assoc; 2020 Jun; 9(11):e016218. PubMed ID: 32419586
[TBL] [Abstract][Full Text] [Related]
3. Effect of Perioperative Antiplatelet Therapy on Outcomes in Patients With Drug-Eluting Stents Undergoing Elective Noncardiac Surgery.
Hong SJ; Kim MJ; Kim JS; Kim EH; Lee J; Ahn CM; Kim BK; Ko YG; Choi D; Hong MK; Jang Y
Am J Cardiol; 2019 May; 123(9):1414-1421. PubMed ID: 30770090
[TBL] [Abstract][Full Text] [Related]
4. One-Month Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention With Zotarolimus-Eluting Stents in High-Bleeding-Risk Patients.
Kandzari DE; Kirtane AJ; Windecker S; Latib A; Kedhi E; Mehran R; Price MJ; Abizaid A; Simon DI; Worthley SG; Zaman A; Choi JW; Caputo R; Kanitkar M; McLaurin B; Potluri S; Smith T; Spriggs D; Tolleson T; Nazif T; Parke M; Lee LC; Lung TH; Stone GW;
Circ Cardiovasc Interv; 2020 Nov; 13(11):e009565. PubMed ID: 33167705
[TBL] [Abstract][Full Text] [Related]
5. Perioperative Antiplatelet Strategy in Patients Undergoing Noncardiac Surgery Within One Year After Percutaneous Coronary Intervention.
Lee SH; Kim C; Shin S; Kim H; Park JK; Oh SJ; Ahn SG; Cho S; Lee OH; Moon JY; Won H; Suh Y; Cho YH; Cho JR; Lee BK; Lee YJ; Lee SJ; Hong SJ; Shin DH; Ahn CM; Kim BK; Ko YG; Choi D; Hong MK; Jang Y; Kim JS
Am J Med; 2023 Oct; 136(10):1026-1034.e1. PubMed ID: 37356644
[TBL] [Abstract][Full Text] [Related]
6. Perioperative management of antiplatelet therapy in patients undergoing non-cardiac surgery following coronary stent placement: a systematic review.
Childers CP; Maggard-Gibbons M; Ulloa JG; MacQueen IT; Miake-Lye IM; Shanman R; Mak S; Beroes JM; Shekelle PG
Syst Rev; 2018 Jan; 7(1):4. PubMed ID: 29321066
[TBL] [Abstract][Full Text] [Related]
7. Platelet Reactivity and Clinical Outcomes After Coronary Artery Implantation of Drug-Eluting Stents in Subjects With Peripheral Arterial Disease: Analysis From the ADAPT-DES Study (Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents).
Gupta R; Kirtane AJ; Ozan MO; Witzenbichler B; Rinaldi MJ; Metzger DC; Weisz G; Stuckey TD; Brodie BR; Mehran R; Ben-Yehuda O; Stone GW
Circ Cardiovasc Interv; 2017 Mar; 10(3):. PubMed ID: 28288963
[TBL] [Abstract][Full Text] [Related]
8. Perioperative management of oral antiplatelet therapy and clinical outcomes in coronary stent patients undergoing surgery. Results of a multicentre registry.
Rossini R; Musumeci G; Capodanno D; Lettieri C; Limbruno U; Tarantini G; Russo N; Calabria P; Romano M; Inashvili A; Sirbu V; Guagliumi G; Valsecchi O; Senni M; Gavazzi A; Angiolillo DJ
Thromb Haemost; 2015 Feb; 113(2):272-82. PubMed ID: 25274620
[TBL] [Abstract][Full Text] [Related]
9. Perioperative implications of newer generation drug-eluting coronary stents: A narrative review.
Milder DA; Kam PC
Anaesth Intensive Care; 2021 Sep; 49(5):338-348. PubMed ID: 34134534
[TBL] [Abstract][Full Text] [Related]
10. Preoperative platelet transfusions to reverse antiplatelet therapy for urgent non-cardiac surgery: an observational cohort study.
Baschin M; Selleng S; Hummel A; Diedrich S; Schroeder HW; Kohlmann T; Westphal A; Greinacher A; Thiele T
J Thromb Haemost; 2018 Apr; 16(4):709-717. PubMed ID: 29383871
[TBL] [Abstract][Full Text] [Related]
11. Adjunctive cilostazol versus double-dose clopidogrel after drug-eluting stent implantation: the HOST-ASSURE randomized trial (Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis-Safety & Effectiveness of Drug-Eluting Stents & Anti-platelet Regimen).
Park KW; Kang SH; Park JJ; Yang HM; Kang HJ; Koo BK; Park BE; Cha KS; Rhew JY; Jeon HK; Shin ES; Oh JH; Jeong MH; Kim S; Hwang KK; Yoon JH; Lee SY; Park TH; Moon KW; Kwon HM; Chae IH; Kim HS
JACC Cardiovasc Interv; 2013 Sep; 6(9):932-42. PubMed ID: 24050860
[TBL] [Abstract][Full Text] [Related]
12. The optimal discontinuation of dual antiplatelet therapy in patients undergoing percutaneous coronary intervention with drug-eluting stents: A meta-analysis of randomized trials.
Wang W; Liu J; Fang J; Liu Y; An T; Zou M; Cheng G
Int J Cardiol; 2017 May; 235():73-86. PubMed ID: 28284499
[TBL] [Abstract][Full Text] [Related]
13. Initial Experience of Bioabsorbable Polymer Everolimus-Eluting Synergy Stents in High-Risk Patients Undergoing Complex Percutaneous Coronary Intervention With Early Discontinuation of Dual-Antiplatelet Therapy.
Noad RL; Hanratty CG; Walsh SJ
J Invasive Cardiol; 2017 Feb; 29(2):36-41. PubMed ID: 27974669
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Effects of Treatment Strategies for Left Main Versus Non-Left Main Bifurcation Percutaneous Coronary Intervention With Current-Generation Drug-Eluting Stent.
Choi KH; Song YB; Lee JM; Park TK; Yang JH; Hahn JY; Choi JH; Choi SH; Kim HS; Chun WJ; Hur SH; Han SH; Rha SW; Chae IH; Jeong JO; Heo JH; Yoon J; Lim DS; Park JS; Hong MK; Doh JH; Cha KS; Kim DI; Lee SY; Chang K; Hwang BH; Choi SY; Jeong MH; Hong SJ; Nam CW; Koo BK; Gwon HC
Circ Cardiovasc Interv; 2020 Feb; 13(2):e008543. PubMed ID: 32069106
[TBL] [Abstract][Full Text] [Related]
15. Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study.
Mehran R; Baber U; Steg PG; Ariti C; Weisz G; Witzenbichler B; Henry TD; Kini AS; Stuckey T; Cohen DJ; Berger PB; Iakovou I; Dangas G; Waksman R; Antoniucci D; Sartori S; Krucoff MW; Hermiller JB; Shawl F; Gibson CM; Chieffo A; Alu M; Moliterno DJ; Colombo A; Pocock S
Lancet; 2013 Nov; 382(9906):1714-22. PubMed ID: 24004642
[TBL] [Abstract][Full Text] [Related]
16. Sex Differences in the Clinical Impact of High Platelet Reactivity After Percutaneous Coronary Intervention With Drug-Eluting Stents: Results From the ADAPT-DES Study (Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents).
Yu J; Mehran R; Baber U; Ooi SY; Witzenbichler B; Weisz G; Rinaldi MJ; Neumann FJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Mazzaferri EL; Brodie BR; Stuckey TD; Maehara A; Xu K; Ben-Yehuda O; Kirtane AJ; Stone GW
Circ Cardiovasc Interv; 2017 Feb; 10(2):. PubMed ID: 28193677
[TBL] [Abstract][Full Text] [Related]
17. Relationship between intravascular ultrasound guidance and clinical outcomes after drug-eluting stents: the assessment of dual antiplatelet therapy with drug-eluting stents (ADAPT-DES) study.
Witzenbichler B; Maehara A; Weisz G; Neumann FJ; Rinaldi MJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Brodie BR; Stuckey TD; Mazzaferri EL; Xu K; Parise H; Mehran R; Mintz GS; Stone GW
Circulation; 2014 Jan; 129(4):463-70. PubMed ID: 24281330
[TBL] [Abstract][Full Text] [Related]
18. Management of antiplatelet therapy in patients with coronary stents undergoing noncardiac surgery: association with adverse events.
Rodriguez A; Guilera N; Mases A; Sierra P; Oliva JC; Colilles C;
Br J Anaesth; 2018 Jan; 120(1):67-76. PubMed ID: 29397139
[TBL] [Abstract][Full Text] [Related]
19. Relationship Between Platelet Reactivity and Ischemic and Bleeding Events After Percutaneous Coronary Intervention in East Asian Patients: 1-Year Results of the PENDULUM Registry.
Nakamura M; Kadota K; Takahashi A; Kanda J; Anzai H; Ishii Y; Shibata Y; Yasaka Y; Takamisawa I; Yamaguchi J; Takeda Y; Harada A; Motohashi T; Iijima R; Uemura S; Murakami Y;
J Am Heart Assoc; 2020 May; 9(10):e015439. PubMed ID: 32394794
[TBL] [Abstract][Full Text] [Related]
20. Stent Thrombosis in Drug-Eluting or Bare-Metal Stents in Patients Receiving Dual Antiplatelet Therapy.
Kereiakes DJ; Yeh RW; Massaro JM; Driscoll-Shempp P; Cutlip DE; Steg PG; Gershlick AH; Darius H; Meredith IT; Ormiston J; Tanguay JF; Windecker S; Garratt KN; Kandzari DE; Lee DP; Simon DI; Iancu AC; Trebacz J; Mauri L;
JACC Cardiovasc Interv; 2015 Oct; 8(12):1552-62. PubMed ID: 26493248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
